Fair Value Calculator Fair Value Calculator
EN DE

1471 (1471) Fair Value & Analysis

Financial Services · Market cap HK$1.5B

1 1471 1471 · HK
PriceHK$10.40
Fair ValueHK$8.45
Upside-18.8%
Quality45/100
Watch 1471 for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range HK$6.34 – HK$10.57

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price −3.7% over the past month.

Price vs Fair Value (12 months)

HK$48.98 HK$9.90 Fair Value HK$8.45 Jun 2025 Jul 2026

12‑month range HK$9.90 – HK$48.98 · fair‑value band HK$6.34 – HK$10.57 · the HK$10.40 price screens above the HK$8.45 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1471 (1471) currently trades at HK$10.40, while our model-based Fair Value estimate is HK$8.45 — implying the stock looks roughly 18.8% overvalued today. We read business quality at 45/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1471 generated revenue of HK$248M at a net margin of 20.8%. Revenue grew 14.6% year over year. It earns a return on equity of 8.5%. The balance sheet holds a net cash position of HK$205M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$248M
Revenue growth (YoY) +14.6%
Net margin 20.8%
Return on equity 8.5%
Free cash flow HK$88.3M FY2025
P/E ratio 24.2
More key figures
Operating margin 23.3%
EPS (TTM) HK$0.1800
Dividend yield 1.5%
EPS growth (YoY) +1.1%
Net cash HK$205M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1471 reported revenue of HK$248M in FY2025 versus HK$120M in FY2021, a compound +19.9%/yr. Reported net income was HK$51.7M in FY2025, compounding +17.6%/yr from FY2021.

Revenue +19.9%/yr
FY21 HK$120M
FY22 HK$148M
FY23 HK$174M
FY24 HK$206M
FY25 HK$248M
Net income +17.6%/yr
FY21 HK$27.0M
FY22 HK$37.8M
FY23 HK$40.4M
FY24 HK$46.7M
FY25 HK$51.7M

Is 1471 fairly valued? → Check now

Similar stocks

6 more Insurance Brokers stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Marsh & McLennan Companies, Inc MRSH $165.44 $112.25 -32%
Aon plc AON $322.24 $181.03 -44%
Arthur J. Gallagher & Co A1JG34 R$559.44 R$350.39 -37%
Willis Towers Watson Public Limited WTW $252.97 $220.92 -13%
Brown & Brown, Inc BRO $60.18 $68.15 +13%
Erie Indemnity Company ERIE $219.51 $163.62 -25%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1471 (1471) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$8.45 versus a price of HK$10.40 — about −19% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1471?
Our model-based fair value for 1471 is HK$8.45 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$10.40.
What is the quality score of 1471?
1471 has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1471 (1471)?
1471 reported trailing-twelve-month revenue of about HK$248M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1471?
The net profit margin of 1471 is about 20.8%, meaning it keeps roughly 20.8% of revenue as net income. Based on the latest reported figures.
Does 1471 pay a dividend?
1471 currently shows a dividend yield of about 1.54% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.